Current HIV/AIDS Reports

Papers
(The TQCC of Current HIV/AIDS Reports is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Spiraling Risk: Visualizing the multilevel factors that socially pattern HIV risk among gay, bisexual & other men who have sex with men using Complex Systems Theory77
Examining the Use of HIV Self-Testing to Support PrEP Delivery: a Systematic Literature Review47
Feasibility and Impact of Community Pharmacy and Novel Pick-up Points for Antiretroviral Therapy Pre-exposure Prophylaxis Initiation and Continuation in Low and Middle-income Countries46
Long-Acting Injectable Cabotegravir for HIV Prevention: What Do We Know and Need to Know about the Risks and Consequences of Cabotegravir Resistance?45
Challenges and Opportunities in Big Data Science to Address Health Inequities and Focus the HIV Response36
Syndemic Theory and Its Use in Developing Health Interventions and Programming: A Scoping Review35
Differentiated Service Delivery Models for Maintaining HIV Treatment and Prevention Services During Crisis and Disease Outbreaks: Lessons from the COVID-19 Pandemic33
Ethical Perspectives in Using Technology-Enabled Research for Key HIV Populations in Rights-Constrained Settings32
Interventions to Improve Adolescent HIV Care Outcomes30
Implementation Science of Integrating Pre-Exposure Prophylaxis in Pharmacist-Led Services in the United States29
Consolidated Overview of Notifiable Adverse Events in the U.S. President’s Emergency Plan for AIDS Relief’s Voluntary Medical Male Circumcision Program Through 202028
More than the Infinite Monkey Theorem: NHP Models in the Development of a Pediatric HIV Cure28
Immunologic Interplay Between HIV/AIDS and COVID-19: Adding Fuel to the Flames?28
Intestinal Microbiota and Aging in People with HIV—What We Know and What We Don’t26
Current Status of HIV-Stigma Reduction Interventions: A Need to Address the Root Causes at Multiple Levels26
Risk Compensation in Voluntary Medical Male Circumcision Programs25
Risk-Based Screening Tools to Optimise HIV Testing Services: a Systematic Review25
COVID-19: Impact on the HIV and Tuberculosis Response, Service Delivery, and Research in South Africa25
PrEP Method Switching: Will it Yield Greater Coverage of HIV Protection? Applying Lessons Learned from Family Planning to Guide Future Research in the Context of PrEP Choice24
Update on Central Nervous System Effects of HIV in Adolescents and Young Adults24
Voluntary Medical Male Circumcision for HIV Prevention: a Global Overview24
Lessons for Understanding Central Nervous System HIV Reservoirs from the Last Gift Program22
Future of bNAbs in HIV Treatment21
Medicinal Plant and Traditional Knowledge-guided Strategies to Combat HIV Persistence19
Transition to Adult Care for Young People Living with HIV19
A Review of Serious Gaming as an Intervention for HIV Prevention19
VMMC Programmatic Successes and Challenges: Western Kenya Case Study18
Awareness of Heightened Sexual and Behavioral Vulnerability as a Trigger for PrEP Resumption Among Adolescent Girls and Young Women in East and Southern Africa17
Sex Differences in Metabolic Disorders of Aging and Obesity in People with HIV17
Ingestible Electronic Sensors for Monitoring Real-time Adherence to HIV Pre-exposure Prophylaxis and Antiretroviral Therapy17
Intervention Approaches to Address Intimate Partner Violence and HIV: a Scoping Review of Recent Research16
Update on Vaccination Recommendations for Adults with HIV16
Getting HIV Pre-exposure Prophylaxis (PrEP) into Private Pharmacies: Global Delivery Models and Research Directions16
HIV Prevention Tools Across the Pregnancy Continuum: What Works, What Does Not, and What Can We Do Differently?16
PEPFAR’s Role in Protecting and Leveraging HIV Services in the COVID-19 Response in Africa15
Mpox and HIV: a Narrative Review15
Long-Acting Injectable Antiretroviral Therapy for Treatment of Human Immunodeficiency Virus: A Review15
Envisioning a Multidisciplinary HBV Cure Research Agenda14
Genomic Exploration of the Brain in People Infected with HIV—Recent Progress and the Road Ahead14
HIV and SARS-CoV-2 Co-infection: Epidemiological, Clinical Features, and Future Implications for Clinical Care and Public Health for People Living with HIV (PLWH) and HIV Most-at-Risk Groups13
The State of the Science on Chronic Comorbidities and Aging in Children and Adolescents with perinatally-acquired HIV13
Fatty Liver Disease: Enter the Metabolic Era13
Long-Acting Injectable Antiretroviral Drugs for Pregnant and Breastfeeding Women: Current Advances, Challenges, and Future Directions13
The Impact of Cannabis Use on Cognition in People with HIV: Evidence of Function-Dependent Effects and Mechanisms from Clinical and Preclinical Studies12
0.11844301223755